Semi-preparative reversed-phase liquid chromatographic purification of oligonucleotides

Importance of the Topic

Oligonucleotide purification is essential to remove synthesis by-products and truncated sequences, ensuring reliable performance in quantitative PCR, forensic human identification and gene transfer studies.

Objectives and Study Overview

This study demonstrates a semi-preparative reversed-phase HPLC workflow for purifying three dual-labeled 25mer oligonucleotides. The targets include fluorescently labeled sequences designed for qPCR, forensic HID and gene transfer applications. Initial sample purities were assessed and the purification protocol optimized for high-resolution fractionation.

Instrumentation Used

• Thermo Scientific Vanquish Flex Analytical Purification LC system
• Vanquish Binary Pump F
• Vanquish Split Sampler FT (1000 μL loop)
• Column Compartment H with active pre-heater
• Diode Array Detector FG (UV 260 nm)
• Integral Vanquish Fraction Collector
• Delay capillary (0.25 × 1500 mm)
• Chromeleon Chromatography Data System v7.3.1

Methodology

A reversed-phase separation was performed on a Waters XBridge BEH C18 OBD column (130 Å, 5 μm, 10 × 100 mm) at 60 °C. Mobile phases consisted of 50 mM triethylammonium acetate (pH 7) with 5% acetonitrile (A) and acetonitrile (B). A gradient from 100% A to 5% A over 32 minutes was applied at 5.0 mL/min. Injection volume was 500 μL and eluents were monitored at 260 nm. Automated fraction collection was controlled with precise timing and valve switching parameters.

Key Results and Discussion

• Initial purities ranged from 89% to 93% for the three dual-labeled oligonucleotides.
• Post-fractionation reanalysis showed 100% relative purity for all target fractions.
• Precise removal of near-baseline impurities and shoulder peaks was achieved through high-resolution fluidics and synchronized fraction collection.
• Chromatographic profiles confirmed reproducible isolation of full-length products without chromatographic separation of dye isomers when not required.

Benefits and Practical Applications

The integrated UHPLC workflow enables rapid, high-throughput purification with minimal manual intervention. High-resolution fluidics of the Vanquish system improve peak sharpness and fraction precision. This approach supports stringent quality control in oligonucleotide manufacturing for diagnostic, forensic and therapeutic uses.

Future Trends and Applications

Advances in stationary phase chemistries and microflow chromatography are expected to further enhance resolution and throughput. Integration of real-time analytics and AI-driven method optimization will accelerate development of customized purification protocols. Scalable platforms may facilitate seamless transition from analytical to manufacturing scales.

Conclusion

The combination of a high-performance UHPLC system with an automated fraction collector and CDS software delivers an efficient, reproducible semi-preparative purification workflow for dual-labeled oligonucleotides. Achieving consistent 100% relative purity demonstrates the method’s suitability for demanding applications in research and diagnostics.

Reference

• Roberts T, Langer R, Wood M (2020) Nature Reviews Drug Discovery 19:673–694
• Zhang Q, Lv H (2016) International Journal of Molecular Sciences 17(12):2134
• Catani M et al. (2020) Biotechnology Journal 15(8):1900226
• Kanwal F et al. (2018) Cellular Physiology and Biochemistry:1915–1927
• Cramer H, Finn K, Herzberg E (2011) CRC Press, Boca Raton, FL
• Thermo Fisher Scientific (n.d.) Technical Note TN-72940